Search

Removal of various soluble metallic impurities from wastewater in semiconductor fabrication plants is a critical issue facing the microelectronics industry. Considering the large volume of wastewater and a highly variable concentration of these contaminants, finding a robust adsorption process using a low-cost sorbent is of great value and interest to this industry. Of particular interest is the development of a flow-through abatement method for treating the process-tool effluent before it is mixed with other wastewaters. In this work, a strain of freshwater green algae (Chlorella sorokiniana), representing an algae-based sorbent, and a simulated wastewater, containing soluble gallium as the metallic impurity, are used as model compounds. The choice of gallium is based on its increased use, and the lack of related adsorption data compared to the information available for other metals such as copper and arsenic. Both batch and continuous-flow operations were used in this study. Comprehensive process models were developed and validated for both batch and flow systems. These models were found to be valuable for understanding the process steps as well as for obtaining the fundamental parameters that are needed for process design and scale-up. The sorbent was found to have high adsorption capacity even at low pH values (14.1 mg/g at pH of 2.3, and 38.5 mg/g at pH of 2.8). Based on the comparison of adsorption rate and capacity with data on previously studied and conventional sorbents, such as activated carbon and ion-exchange resins, the use of this algae-based sorbent is potentially an attractive option for the removal of gallium from the process-tool wastewater.

We review the book “Behavioural Rationality and Heterogeneous Expectations in Complex Economic Systems” written by Cars Hommes and discuss the research trends on the dynamic interaction between heterogeneous investment and complex asset price movements.

This paper investigates the existence and uniqueness of solutions to neutral stochastic functional differential equations with pure jumps (NSFDEwPJs). The boundedness and almost sure exponential stability are also considered. In general, the classical existence and uniqueness theorem of solutions can be obtained under a local Lipschitz condition and linear growth condition. However, there are many equations that do not obey the linear growth condition. Therefore, our first aim is to establish new theorems where the linear growth condition is no longer required whereas the upper bound for the diffusion operator will play a leading role. Moreover, the pth moment boundedness and almost sure exponential stability are also obtained under some loose conditions. Finally, we present two examples to illustrate the effectiveness of our results.

The exponential stability of trivial solution and the numerical solution for neutral stochastic functional differential equations (NSFDEs) with jumps is considered. The stability includes the almost sure exponential stability and the mean-square exponential stability. New conditions for jumps are proposed by means of the Borel measurable function to ensure stability. It is shown that if the drift coefficient satisfies the linear growth condition, the Euler-Maruyama method can reproduce the corresponding exponential stability of the trivial solution. A numerical example is constructed to illustrate our theory.

Hydrogen sulfide (H2S) is involved in cancer biological processes. However, there are several controversies concerning the role of H2S in cancer development and progression. In this study, we found that the growth and migration of hepatocellular carcinoma (HCC) cells were enhanced by 10–100 μM NaHS and dose-dependently inhibited by 600–1000 μM NaHS. The apoptotic levels were reduced by 25–100 μM NaHS but increased by 400–1000 μM NaHS in HCC cells. After treatment with 25–50 μM NaHS, the protein levels of p-EGFR, p-ERK, MMP-2, and p-AKT were increased, whereas the levels of PTEN and the ratio of BAX/BCL-2 were down-regulated. Administration of 800–1000 μM NaHS showed opposite effects on these protein levels in HCC cells. However, H2S showed no effects on the growth, migration, apoptosis, and the protein levels of the EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways in L02 cells. Furthermore, 25–100 μM NaHS promoted HCC tumor growth and blood vessel formation, while 800–1000 μM NaHS inhibited angiogenesis and tumor growth with no obvious systemic toxicity. These results indicate that H2S acts as a double-edged sword in HCC cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways. Novel H2S donors could be designed and applied for further antitumor research.

T-cell acute lymphoblastic leukaemia (T-ALL) is a blood malignancy afflicting mainly children and adolescents1. T-ALL patients present at diagnosis with increased white cell counts and hepatosplenomegaly, and are at an increased risk of central nervous system (CNS) relapse2,3. For that reason, T-ALL patients usually receive cranial irradiation in addition to intensified intrathecal chemotherapy. The marked increase in survival is thought to be worth the considerable side-effects associated with this therapy. Such complications include secondary tumours, neurocognitive deficits, endocrine disorders and growth impairment3. Little is known about the mechanism of leukaemic cell infiltration of the CNS, despite its clinical importance4. Here we show, using T-ALL animal modelling and gene-expression profiling, that the chemokine receptor CCR7 (ref. 5) is the essential adhesion signal required for the targeting of leukaemic T-cells into the CNS. Ccr7 gene expression is controlled by the activity of the T-ALL oncogene Notch1 and is expressed in human tumours carrying Notch1-activating mutations. Silencing of either CCR7 or its chemokine ligand CCL19 (ref. 6) in an animal model of T-ALL specifically inhibits CNS infiltration. Furthermore, murine CNS-targeting by human T-ALL cells depends on their ability to express CCR7. These studies identify a single chemokine–receptor interaction as a CNS ‘entry’ signal, and open the way for future pharmacological targeting. Targeted inhibition of CNS involvement in T-ALL could potentially decrease the intensity of CNS-targeted therapy, thus reducing its associated short- and long-term complications.